Skip to main content
ProBiotix Health Plc logo

ProBiotix Health Plc — Investor Relations & Filings

Ticker · PBX ISIN · GB00BLNBFR86 LEI · 98450048683CF0388C30 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 66 across all filing types
Latest filing 2024-08-08 Declaration of Voting R…
Country GB United Kingdom
Listing Aquis Stock Exchange PBX

About ProBiotix Health Plc

https://www.probiotixhealth.com/

ProBiotix Health Plc is a life sciences company that develops and supplies scientifically validated, probiotic-based microbiome solutions. The company specializes in formulations for cardiometabolic health, targeting conditions related to cholesterol, blood pressure, and vascular health, as well as healthy aging. Its core technology is LPLDL®, a patented and trademarked Lactobacillus plantarum strain demonstrated in human clinical trials to be effective in managing key cardiometabolic markers. ProBiotix Health offers its technology as both a raw ingredient and in finished product formulations, such as the YourBiotix and CholBiome® lines, for the global dietary supplement market. The company's approach is rooted in extensive research and development, conducted in collaboration with universities and scientific advisors to ensure product efficacy and safety.

Recent filings

Filing Released Lang Actions
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement from ProBiotix Health PLC regarding the 'Result of AGM'. It confirms that all resolutions were passed during the Annual General Meeting. According to the filing definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the specific category for official results from shareholder votes at any general meeting.
2024-08-08 English
New appointment
Regulatory Filings Classification · 95% confidence The document is a press release announcing the appointment of a new Head of Marketing at ProBiotix Health plc. While it mentions a management change, it is a non-regulatory 'Reach' announcement distributed via RNS. Since it does not fit into the specific categories of Board/Management Information (which typically refers to Board of Directors or C-suite changes) and is a general corporate news release, it is best classified as a Regulatory Filing (RNS) under the fallback category.
2024-07-29 English
Six month trading update
Earnings Release Classification · 95% confidence The document is a 'Six month trading update' issued by ProBiotix Health plc. It provides key financial highlights (turnover, gross profit, EBITDA) for the six months ending 30 June 2024. Crucially, the text explicitly states: 'The Company expects to announce its interim results for the 6 months ended 30 June 2024 during the second half of August 2024.' This confirms that the current document is a preliminary trading update/announcement of results, not the full interim report itself. Therefore, it falls under the Earnings Release (ER) category as it provides initial financial highlights for a period. H1 2024
2024-07-15 English
Final Results
AGM Information Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from ProBiotix Health PLC. It contains the company's 'Final results' for the period ended 31 December 2023, highlights of the year, and a 'Notice of AGM'. While it contains a 'Chairman and Chief Executive's Report' section, the document itself is a regulatory announcement (RNS) that serves as a summary and notification of the release of the full annual report and the upcoming AGM. According to the 'Menu vs Meal' rule, since this is a regulatory announcement providing highlights and notice of other events, it is classified as an RNS.
2024-06-28 English
Partner agreement with SymbioPharm
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the Regulatory News Service (RNS) regarding a new partnership agreement between ProBiotix Health plc and SymbioPharm. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category.
2024-02-26 English
Change of auditor
Regulatory Filings Classification · 98% confidence The document is a short regulatory announcement (RNS) regarding a change of auditor for ProBiotix Health plc. It does not fit into specific categories like board changes (MANG) or legal proceedings (LTR), and since it is a general regulatory announcement regarding corporate governance/administrative updates that does not fall into the other specific buckets, it is classified as a Regulatory Filing (RNS).
2024-02-09 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.